BIO-TECHNE TO PRESENT AT INVESTOR CONFERENCES
Bio-Techne (NASDAQ: TECH) has announced its participation in three upcoming investor conferences in November 2024. The company will present at the UBS Global Healthcare Conference on November 12 at 9:30 AM PST, the Stifel 2024 Healthcare Conference on November 19 at 8:00 AM EST, and the Stephens NASH 2024 Conference on November 20 at 11:00 AM CST. Interested parties can access live webcasts of all presentations through Bio-Techne's Investor Relations website's IR Calendar page.
Bio-Techne (NASDAQ: TECH) ha annunciato la sua partecipazione a tre prossime conferenze per investitori nel novembre 2024. L'azienda presenterà alla UBS Global Healthcare Conference il 12 novembre alle 9:30 AM PST, alla Stifel 2024 Healthcare Conference il 19 novembre alle 8:00 AM EST e alla Stephens NASH 2024 Conference il 20 novembre alle 11:00 AM CST. Le parti interessate possono accedere alle dirette web di tutte le presentazioni attraverso la pagina del Calendario IR del sito web per le Relazioni con gli Investitori di Bio-Techne.
Bio-Techne (NASDAQ: TECH) ha anunciado su participación en tres próximas conferencias para inversores en noviembre de 2024. La compañía presentará en la Conferencia Global de Salud de UBS el 12 de noviembre a las 9:30 AM PST, en la Conferencia de Salud Stifel 2024 el 19 de noviembre a las 8:00 AM EST y en la Conferencia Stephens NASH 2024 el 20 de noviembre a las 11:00 AM CST. Las partes interesadas pueden acceder a las transmisiones en vivo de todas las presentaciones a través de la página del Calendario IR en el sitio web de Relaciones con Inversores de Bio-Techne.
Bio-Techne (NASDAQ: TECH)는 2024년 11월에 있을 세 개의 투자자 회의에 참석할 것이라고 발표했습니다. 회사는 11월 12일 오전 9시 30분 PST에 UBS 글로벌 헬스케어 회의에서 발표하며, 11월 19일 오전 8시 EST에 Stifel 2024 헬스케어 회의와 11월 20일 오전 11시 CST에 Stephens NASH 2024 회의에서 발표할 예정입니다. 관심 있는 분들은 Bio-Techne의 투자자 관계 웹사이트의 IR 캘린더 페이지를 통해 모든 발표의 라이브 웹캐스트에 접근할 수 있습니다.
Bio-Techne (NASDAQ: TECH) a annoncé sa participation à trois prochaines conférences pour investisseurs en novembre 2024. La société présentera lors de la Conférence Mondiale sur la Santé UBS le 12 novembre à 9h30 PST, lors de la Conférence Sanitaire Stifel 2024 le 19 novembre à 8h00 EST et lors de la Conférence Stephens NASH 2024 le 20 novembre à 11h00 CST. Les parties intéressées peuvent accéder aux diffusions en direct de toutes les présentations via la page du Calendrier IR du site Web des Relations avec les Investisseurs de Bio-Techne.
Bio-Techne (NASDAQ: TECH) hat seine Teilnahme an drei bevorstehenden Investorenkonferenzen im November 2024 angekündigt. Das Unternehmen wird am 12. November um 9:30 Uhr PST bei der UBS Global Healthcare Conference präsentieren, am 19. November um 8:00 Uhr EST bei der Stifel 2024 Healthcare Conference und am 20. November um 11:00 Uhr CST bei der Stephens NASH 2024 Conference. Interessierte Parteien können über die IR-Kalenderseite auf der Investor Relations-Website von Bio-Techne Live-Streams aller Präsentationen abrufen.
- None.
- None.
UBS Global Healthcare Conference
November 12, 2024
9:30 AM PST
Stifel 2024 Healthcare Conference
November 19, 2024
8:00 AM EST
Stephens NASH 2024 Conference
November 20, 2024
11:00 AM CST
A live webcast of the presentations can be accessed via the IR Calendar page of Bio-Techne's Investor Relations website at https://investors.bio-techne.com/ir-calendar.
About Bio-Techne
Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. With hundreds of thousands of products in its portfolio, Bio-Techne generated approximately
Contact: | David Clair, Vice President, Investor Relations & Corporate Development |
612-656-4416 | |
View original content to download multimedia:https://www.prnewswire.com/news-releases/bio-techne-to-present-at-investor-conferences-302298610.html
SOURCE Bio-Techne Corporation
FAQ
When is Bio-Techne (TECH) presenting at the UBS Global Healthcare Conference in 2024?
Which investor conferences will Bio-Techne (TECH) attend in November 2024?
How can investors access Bio-Techne's (TECH) conference presentations in November 2024?
What time is Bio-Techne's (TECH) presentation at the Stephens NASH 2024 Conference?
